Moreover, BORIS sf1 was found to be expressed in many types of primary cancers, including retinoblastoma, chronic myelogenous leukemia, and mucoepidermoid carcinoma (Table S5). This evidence concerns the gene SF1 and chronic myelogenous leukemia, BCR-ABL1 positive.